Name | SK1-IN-1 |
---|---|
Synonyms |
(3S)-N-[(1S)-1-{4-[5-(2-Cyclopentylethyl)-1,2,4-oxadiazol-3-yl]phenyl}ethyl]-3-hydroxy-L-prolinamide
2-Pyrrolidinecarboxamide, N-[(1S)-1-[4-[5-(2-cyclopentylethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]-3-hydroxy-, (2S,3S)- |
Description | SK1-IN-1 is a potent sphingosine kinase 1 (SPHK1) inhibitor with an IC50 of 58 nM. |
---|---|
Related Catalog | |
Target |
IC50: 58 nM (SPHK1)[1] |
In Vivo | SK1-IN-1 demonstrates significant improvement in the intrinsic clearance, particularly against human liver microsomes. SK1-IN-1 is selected for rat PK studies and demonstrates modest in oral bioavailability with acceptable half-lives in blood circulation[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C22H30N4O3 |
Molecular Weight | 398.499 |
Exact Mass | 398.231781 |
LogP | 2.39 |
Index of Refraction | 1.571 |
Storage condition | 2-8℃ |